Over 1500 New Jersey Auctions End Tomorrow 03/30 - Bid Now
Over 70 Total Lots Up For Auction at One Location - CA 04/07

Leading UK diagnostics provider source LDPath expands AI capabilities with Ibex Medical Analytics

Press releases may be edited for formatting or style | December 07, 2022 Artificial Intelligence

Dr. Alistair Robson, FRCPath, DipRCPath and Medical Director of Source LDPath added, "I have seen first-hand how transformative and impactful AI-powered tools can be for a pathologist's work. I am encouraged by the continued rollout of Ibex AI across UK hospital trusts and am looking forward to seeing Ibex's newly announced biomarker scoring tools helping breast pathologists improve diagnosis of IHC stained slides."

"We are thrilled to expand the deployment of our innovative AI technology, already used in routine clinical practice in the UK, into additional NHS trusts," said Stuart Shand, Ibex Medical Analytics Chief Commercial Officer. "It is exciting to see our Galen platform become available to many more pathology services through our partnership with Source, empowering pathologists who face unprecedented case-loads and helping oncologists improve care for cancer patients."

About Ibex Medical Analytics
Ibex Medical Analytics (Ibex) is transforming cancer diagnostics with world-leading, clinical grade AI-powered solutions, empowering physicians to provide accurate, timely and personalized cancer diagnosis for every patient. Our Galen™ suite of solutions is the first and most widely deployed AI-technology in pathology and used as part of everyday routine, supporting pathologists and providers worldwide in improving the quality and accuracy of diagnosis, implementing comprehensive quality control, reducing turnaround times and boosting productivity with more efficient workflows. Ibex's Artificial Intelligence technology is built on Deep Learning algorithms trained by a team of pathologists, data scientists and software engineers.

About Source LDPath
Source LDPath, a part of Source BioScience, specializes in digitalizing pathology diagnostics with its ground-breaking bespoke modular digital pathology and AI, transforming surgical pathology reporting for client laboratories. Marked improvement of turnaround times, from sample receipt to pathology report, and seamless integration of AI analytics, facilitates patient management and rapid access to appropriate treatment. We are your expert guiding hand in digital pathology and AI integration.

Back to HCB News

You Must Be Logged In To Post A Comment